Abstract. The purposes of this study are to estimate cumulative incidence and risk ratio for osteonecrosis of the jaw (ONJ) after tooth extraction in patients with and without administration of bisphosphonates (BP) and to identify potential risk factors for bisphosphonate-induced osteonecrosis of the jaw (BIONJ). A cohort study was conducted in all patients undergoing tooth extraction at a university hospital in Japan 
Introduction
Bisphosphonates (BP) are used for the treatment of a range of bone involvement, such as osteoporosis or bone metastases of malignant cancer, and their efficacy in preventing further bone damage, reducing bone pain, and increasing bone mineral density has been confirmed. Nevertheless, in 2003 Marx reported bisphosphonate-related osteonecrosis of the jaw or bisphosphonate-induced osteonecrosis of the jaw (BIONJ), as a side effect of BP treatment 1 . However, the incidence and mechanism of BIONJ have not been accurately determined.
Since that initial report, the association between BP exposure and the incidence of osteonecrosis of the jaw (ONJ) has been clarified in several case series, reviews, epidemiologic studies and clinical trials [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , which reported a prevalence of BIONJ ranging from 0.7% to 18.6% on intravenous [5] [6] [7] and 0.01% to 4.3% on oral administration 8, 9 . Nevertheless, the low incidence of ONJ among BP-naïve patients has prevented any direct estimation of the risk ratio of ONJ among patients receiving BP.
Black et al. indentified only 1 patient with possible ONJ among 3852 postmenopausal women during a 3-year period 10 . In their 6-year population-based cohort study using medical claims data, Wilkinson et al. found that 0.30% of naïve patients had been diagnosed with inflammatory conditions or osteomyelitis of the jaw but not ONJ 11 . 5 Tooth extraction has been reported to be the main initiating factor and one of the most common risk factors for BIONJ among patients receiving BP (approximately 86% of cases) 8, 12, 13 , and relative risk of BIONJ in these patients is 5.3 to 53 times higher than in BP patients who do not experience tooth extraction 5, 14, 15 . A current guideline recommends non-surgical treatment rather than tooth extraction in dental patients at high risk of BIONJ 16 , but given that bacterial infection is itself reported as a critical risk factor for BIONJ 16 , avoiding extraction might be problematic in cases in which the bacterial infection remains. Further, information on the incidence or risk factors for BIONJ after tooth extraction among patients receiving BP is limited. A better understanding of this condition, particularly with regard to risk factors and incidence, will be helpful to dentists in the care of patients receiving treatment with BP.
The purpose of this study was to estimate the cumulative incidence and risk ratio for ONJ after tooth extraction in patients with and without administration of BP, and to identify potential risk factors for BIONJ, including oral status.
Materials and methods

Study design and cohort
We conducted a retrospective analysis of patients who had undergone tooth extraction 
.
Intravenous BP have not been approved for osteoporosis in Japan.
For patients treated with BP in the hospital, we entered these medications into the electronic medical record system to obtain the type and duration of BP administration, and the number of patients administered them to estimate the incidence of BIONJ. For patients treated with BP in other hospitals, we reviewed the record of their first examination at our hospital, at which we recorded the type and duration of BP administration as obtained from the referring physician by letter.
Measurement of oral status
Using the patient's panoramic radiograph before tooth extraction, an experienced examiner calculated the DMF index and severity of alveolar bone loss. The DMF index, which comprises the number of decayed (D), missing (M), and filled (F) teeth, has been established as a key measurement of caries experience in dental epidemiology 17 . In addition, the severity of alveolar bone loss was measured to examine periodontal status as a percentage of missing bone at the mesial and distal surfaces of each tooth present 18 .
Severity was estimated from (a-b)/a×100 (%) using the panoramic radiograph (a, 9 distance from radiographic apex to cement-enamel junction (mm); b, distance from radiographic apex to interproximal alveolar bone crest (mm)). If the location of the cemento-enamel junction was obscured by interproximal fillings, the cervical margin of these fillings was chosen as standard. If the cervical margin of these fillings was obscured, bone loss height was characterized as unmeasurable. Each tooth surface was assigned a score corresponding to a bone loss of 0% to 24%, 25% to 49%, 50% to 74%, and 75% to 100%, respectively. These measurements were then averaged to yield a single mean bone loss score for each patient, with a higher score indicating more severe periodontal disease 19 .
Statistical analysis
The incidence of ONJ was calculated using the cumulative incidence method, which is defined as the number or proportion of a cohort of people who experience the onset of ONJ during a specified time interval 20 . In the calculation of the CI for incidence, the Poisson distribution was used. Medians for continuous variables were compared using the Wilcoxon rank-sum test. Proportions across levels of categorical variables were compared using the Fisher exact test. Risk ratios were calculated for all dichotomous variables and Wald CIs were calculated 20 . All P values were two sided at a significance level of 5%. For missing data, available-case analysis was performed in addition to multiple imputation analysis. All statistical analysis was performed using Stata 11.2 software (Stata Corporation, College Station, TX, USA).
Results
Patient characteristics
A total of 3240 patients underwent tooth extraction at our institute. Regarding oral status among patients receiving BP, we found a significant association between the incidence of BIONJ and bone loss score but not DMF index.
The median bone loss score among BIONJ patients was significantly higher than that among those without BIONJ (P = 0.024) (Table 4) : namely, while median bone loss score among those without BIONJ was 1.3 (interquartile range 1.1 to 1.6) and the prevalence of severe periodontal status was 7.4%, median score among BIONJ patients 13 was 1.6 (interquartile range 1.5 to 1.9) and the prevalence of severe periodontal status was 20.0%. Similarly, this association was significantly found among patients aged 65 years or older (median, 1.4 vs. 1.6, P = 0.034).
Missing data
Potential risk factors were not available for eight patients, namely the duration of BP administration for one patient and current alcoholic intake and current smoking for seven patients. We therefore performed available-case analysis (Table 4 and Table 5 ).
Additionally, we also performed multiple imputation analysis, but the results did not change from those of available-case analysis (data not shown).
Discussion
We found that the cumulative incidence of ONJ among patients who had received BP administration was significantly higher than that among patients who had not received this treatment (crude risk ratio 122.6, 95% CI: 14.4 to 1041.8). To our knowledge, this study is the first cohort study to evaluate the cumulative incidence and risk ratio for ONJ after tooth extraction among patients with or without BP administration.
Additionally, risk ratio for ONJ was particularly elevated in the subpopulation of In the DPBRN study, the investigators had so little hospital information that they could not estimate the risk ratio of intravenous BP 21 . In our study, although a single-center study, we were able to collect detailed BP administrative data from the hospital database and estimate the risk ratio stratified by the route of BP administration.
In addition, oral and maxillofacial surgeons followed up all patients after tooth extraction, diagnosed ONJ, and excluded patients with non BP-induced ONJ. This extraction of detailed information and manual confirmation of ONJ likely improved the reliability of our results.
Previous studies have reported that preventative dental treatment decreased BIONJ risk among patients with intravenous BP administration [22] [23] [24] . All patients who consulted the outpatient clinic of our department before BP administration underwent an oral examination, screening for periodontal disease, and oral cleaning. For patients receiving BP, particularly intravenous BP, an extensive oral examination was performed and preventive dental treatment was conducted if needed. When tooth extraction was required following ineffective conservative treatment, preventive dental treatment was performed before extraction in all patients receiving BP, and extraction was conducted with particular care and antibiotic use, with complete wound closure when possible. 15 . The results of our present study are consistent with these other studies which also employed positive preventive dental treatment before tooth extraction, and better than that of the study which did not describe the use of preventive care 15 . Periodontal disease, an infection caused by oral bacteria, is characterized by inflammation that leads to alveolar bone loss 27 . In this study, we found that not only intravenous BP administration but also the loss of alveolar bone was associated with an increased risk of BIONJ after tooth extraction. Given that all patients with BP administration underwent preventive and therapeutic treatment of oral bacteria before tooth extraction and that any effect of infection at the time of extraction was accordingly minimum, our findings suggest that previous inflammation of periodontal tissue may predispose to BIONJ after tooth extraction.
Several limitations of this study warrant mention. First, large differences were seen in age and prevalence of cancer or osteoporosis between BP and BP-naïve patients. We therefore performed stratified analysis by age and route of BP administration to estimate risk ratios for ONJ to control for these factors. However, due to the limited number of events, we were unable to estimate relative risks adjusted for the other potential risk factors such as steroid use or smoking, and the 95% CIs were wide. This prevents the drawing of any reliable conclusions from the results, and indicates the need to evaluate possible risk factors or relative risks in a larger number of patients with ONJ, or to conduct a case-control study. Second, selection bias is inherent to single-center studies, and the present study was additionally subject to inherent referral bias toward the selection of more severe cases, given that our department is a lead institution for oral and maxillofacial surgery in Kyoto City. A positive aspect of this latter limitation, however, is that almost all patients consult our department again in the event of subsequent problems at the tooth extraction site. Additionally, ONJ is an uncommonly encountered clinical condition, and such patients are likely to be referred to our clinic to establish a diagnosis. The impact of selection bias is thus somewhat unclear. Subsequent multicenter regional (or national) studies would be required to address this bias. Third, we were unable to eliminate the possibility that some of the patients who developed ONJ might have had unidentified ONJ in the submucosa at the time of tooth extraction, hampering assessment of the impact of tooth extraction on ONJ development. A comprehensive understanding of the mechanism of ONJ therefore awaits additional studies.
In conclusion, BP administration, particularly intravenous administration, is associated with an increased risk of ONJ after tooth extraction. Severe alveolar bone loss might be a risk factor for BIONJ after tooth extraction. This study provides important information for physicians and dentists concerned with the prevention of ONJ in patients receiving BP.
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